Howard Sofen
15PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Dec 05, 2025
Deucravacitinib in Plaque Psoriasis After Inadequate Response to Apremilast: Phase 3 POETYK Analysis.April W Armstrong, Richard B Warren, Howard Sofen
|Mar 06, 2025
Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials.April W Armstrong, Mark Lebwohl, Richard B Warren
|Feb 07, 2025
Deucravacitinib: Adverse Events of Interest Across Phase 3 Plaque Psoriasis Trials.Joseph F Merola, Laura K Ferris, Jeffrey M Sobell
|Jan 08, 2025
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children.Eric L Simpson, Adelaide A Hebert, John Browning
|Jun 30, 2024
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials.Neil J Korman, Richard B Warren, Jerry Bagel
Pageof 3
Frequent Collaborators
5 joint publications
Richard B Warren
3 joint publications
Bruce Strober
3 joint publications
Kim Papp
3 joint publications
Diamant Thaçi
3 joint publications
Andrew Blauvelt
3 joint publications
April W Armstrong
2 joint publications
Mark Lebwohl
2 joint publications
Akimichi Morita
2 joint publications
Carle Paul
2 joint publications
Linda Stein Gold